• info@ncpbrussels.be
  • +32 2 422 00 21

Home

Tuesday, 09 July 2013 18:56

IMI’s 9th Call for proposals

Written by Mathilde VIVOT
Rate this item
(0 votes)
Print

The Innovative Medicines Initiative (IMI) has launched its 9th Call for proposals, giving researchers from diverse sectors the opportunity to participate in ambitious public-private partnerships that will pave the way for the development of the medicines of the future.                              ...

The Innovative Medicines Initiative (IMI) has launched its 9th Call for proposals, giving researchers from diverse sectors the opportunity to participate in ambitious public-private partnerships that will pave the way for the development of the medicines of the future.                                                                                                           IMI’s 9th Call for proposals

About IMI
As the world’s largest public-private partnership in drug research, IMI is revolutionising the way pharmaceutical research is performed, by offering a new and unique model for public-private collaboration.
Through its €2 billion research programme, IMI aims to speed up the discovery and development of safer and more effective drugs for patients, and to reinvigorate the biopharmaceutical sector in Europe.

9th Call topics

-  WEBAE – Leveraging emerging technologies for pharmacovigilance
-  Developing innovative therapeutic interventions against physical frailty and sarcopenia (ITI-PF&S) as a prototype geriatric indication
-  Driving re-investment in R&D and responsible use of antibiotics (antimicrobial resistance programme topic 4)
- Clinical development of antibacterial agents for Gram-negative antibiotic resistant pathogens (antimicrobial resistance programme topic 5)

This Call for proposals is likely to be of particular interest to experts in the following areas: medical research, drug development, geriatrics, medicines safety, pharmacovigilance, social media, public health, business models, economics, antibiotics, antimicrobial resistance.
IMI warmly encourages small and medium-sized enterprises (SMEs), patients’ organisations, regulatory authorities, academic teams, industry, hospitals and other organisations to form consortia and apply for participation in the new IMI projects.

Funding rules
Budget: €135 370 000
Deadline for submitting Expressions of Interest: 9 October 2013

Why apply?

- Take part in patient-centric biomedical / pharmaceutical research
- Join unique consortia involving top teams from industry, academia, SMEs, regulators, and others
- Obtain research funding                                    
- Boost the visibility and status of your organisation in Europe and globally and gain access to new markets

Read 7270 times Last modified on Tuesday, 03 October 2017 08:57

Leave a comment

Make sure you enter all the required information, indicated by an asterisk (*). HTML code is not allowed.